Prot# CRAD001A US09: A Prospective, Multicenter, Open-Label, Randomized Study of Safety, Tolerability & Efficacy of Certican® (RAD001) w/ Simulect®, Corticosteroids & Lower Levels Versus Higher Levels of Tacrolimus in de novo Renal Transplant Recipients

Project: Research project

Project Details

StatusFinished
Effective start/end date10/17/034/30/05

Funding

  • Novartis Pharmaceuticals Corporation (CRAD001A US09)